ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹143 Cr | ₹466 Cr | ₹757 Cr | ₹67 Cr | ₹33 Cr |
What is the latest Total Non-Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹143 Cr |
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹757 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹33 Cr |
How is Total Non-Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹143 Cr | -69.37 | |
| Mar2025 | ₹466 Cr | -38.43 | |
| Mar2024 | ₹757 Cr | 1,023.14 | |
| Mar2023 | ₹67 Cr | 106.11 | |
| Mar2022 | ₹33 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,986.3 Cr | -0.3% | 1.3% | 46.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -0.3% |
1.3% |
46.3% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses